Literature DB >> 339850

Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients.

R F Shapiro, C N Gamble, K B Wiesner, J J Castles, A W Wolf, E J Hurley, A F Salel.   

Abstract

The possible contribution of immunological mechanisms in the development of Libman-Sacks endocarditis was studied in 2 patients with systemic lupus erythematosus who underwent aortic valve replacement. Sections of verrucous lesions, stained with haematoxylin and eosin, showed three apparently distinct zones: an outer exudative zone of fibrin, nuclear debris, and haematoxylin-stained bodies; a middle organizing zone of proliferating capillaries and fibroblasts; and an inner zone of neovascularization which showed distinct, thin-walled junctional vessels. The striking finding was the apparently selective deposition of immunoglobulins and complement identified by direct immunofluorescence, within the walls of the small junctional vessels of the zone of neovascularization. We suggest that the observed immune deposits are immune complexes and that circulating immune complexes may play a critical role in the growth and proliferation of the verrucous lesion.

Entities:  

Mesh:

Year:  1977        PMID: 339850      PMCID: PMC1000155          DOI: 10.1136/ard.36.6.508

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement.

Authors:  S A Paget; B H Bulkley; L E Grauer; R Seningen
Journal:  Am J Med       Date:  1975-07       Impact factor: 4.965

2.  A Millipore filter assay for antibodies to native DNA in sera of patients with systemic lupus erythematosus.

Authors:  B Ginsberg; H Keiser
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

3.  The choroid plexus in systemic lupus erythematosus.

Authors:  C J Atkins; J J Kondon; F P Quismorio; G J Friou
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

Review 4.  Mechanisms of renal injury in systemic lupus erythematosus.

Authors:  D Koffler; H G Kunkel
Journal:  Am J Med       Date:  1968-08       Impact factor: 4.965

5.  The fourth component of complement in the cerebrospinal fluid in systemic Lupus erythematosus.

Authors:  N M Hadler; R D Gerwin; M M Frank; J N Whitaker; M Baker; J L Decker
Journal:  Arthritis Rheum       Date:  1973 Jul-Aug

6.  Mitral valve replacement for mitral regurgitation due to Libman-Sacks endocarditis. Report of a case.

Authors:  P D Myerowitz; L L Michaelis; C L McIntosh
Journal:  J Thorac Cardiovasc Surg       Date:  1974-06       Impact factor: 5.209

7.  Complement in pericardial fluid of lupus erythematosus. Studies in two patients.

Authors:  G G Hunder; B J Mullen; F C McDuffie
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

8.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

Authors:  B H Bulkley; W C Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

9.  DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera.

Authors:  R J Harbeck; E J Bardana; P F Kohler; R I Carr
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

10.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

View more
  9 in total

1.  Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.

Authors:  O Meyer; M Golstein; P Nicaise; C Labarre; M F Kahn
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 2.  Systemic lupus erythematosus clinical issues.

Authors:  M B Stevens
Journal:  Springer Semin Immunopathol       Date:  1986

3.  Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.

Authors:  José Pardos-Gea; Josefina Cortés-Hernández; Jesus Castro-Marrero; Eva Balada; José Ordi-Ros
Journal:  Clin Rheumatol       Date:  2017-03-10       Impact factor: 2.980

4.  Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

Authors:  R Cervera; J Font; C Paré; M Azqueta; F Pérez-Villa; A López-Soto; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 5.  Revisiting Libman-Sacks endocarditis: a historical review and update.

Authors:  Jennifer L Lee; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

6.  Mitral regurgitation due to lupus endocarditis treated with valve replacement.

Authors:  F J Brennan; S E Ford; P M Ford; P A Morrin; G W Burggraf; T A Salerno
Journal:  Can Med Assoc J       Date:  1983-09-15       Impact factor: 8.262

7.  Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks.

Authors:  R A Asherson; D G Gibson; D W Evans; E Baguley; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

Review 8.  Cardiovascular lesions in collagen-vascular diseases.

Authors:  V J Ferrans; E R Rodríguez
Journal:  Heart Vessels Suppl       Date:  1985

9.  An unusual presentation of lupus in a pediatric patient.

Authors:  Vimal Master Sankar Raj
Journal:  Case Rep Pediatr       Date:  2013-08-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.